SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-023031
Filing Date
2022-08-16
Accepted
2022-08-16 17:04:47
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166068387178496.html 4  
1 FORM 4 wf-form4_166068387178496.xml 4 3980
  Complete submission text file 0001628280-22-023031.txt   5469
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 3730 KIRBY DRIVE, STE. 1200 HOUSTON TX 77098
Business Address
Scripture Charity (Reporting) CIK: 0001895948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 221170972